Found: 124
Select item for more details and to access through your institution.
Optimizing Outcomes through a Multidisciplinary Team Approach in Endometrial Cancer.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 1, p. 64, doi. 10.3390/healthcare12010064
- By:
- Publication type:
- Article
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-018-0691-4
- By:
- Publication type:
- Article
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 3, p. 290, doi. 10.1007/s12185-014-1634-7
- By:
- Publication type:
- Article
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1198992
- By:
- Publication type:
- Article
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1182971
- By:
- Publication type:
- Article
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell'Adulto Multiple Myeloma Working Party study
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s13287-015-0033-1
- By:
- Publication type:
- Article
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 64, doi. 10.1186/s13287-015-0033-1
- By:
- Publication type:
- Article
Immunologic and molecular evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical remission phase.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 853, doi. 10.1111/bjh.16434
- By:
- Publication type:
- Article
Serum levels of soluble calreticulin predict for time to first treatment in early chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 983, doi. 10.1111/bjh.13907
- By:
- Publication type:
- Article
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 3, p. 455, doi. 10.1111/bjh.13117
- By:
- Publication type:
- Article
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 224, doi. 10.1111/bjh.13032
- By:
- Publication type:
- Article
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13032
- By:
- Publication type:
- Article
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 629, doi. 10.1111/bjh.12800
- By:
- Publication type:
- Article
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim.
- Published in:
- Journal of Clinical Apheresis, 2005, v. 20, n. 3, p. 129, doi. 10.1002/jca.20049
- By:
- Publication type:
- Article
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. E157, doi. 10.1002/ajh.26927
- By:
- Publication type:
- Article
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E24, doi. 10.1002/ajh.26779
- By:
- Publication type:
- Article
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E306, doi. 10.1002/ajh.26235
- By:
- Publication type:
- Article
Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E269, doi. 10.1002/ajh.26201
- By:
- Publication type:
- Article
Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E168, doi. 10.1002/ajh.26127
- By:
- Publication type:
- Article
Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0024313
- By:
- Publication type:
- Article
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 1, p. 25, doi. 10.1007/s00277-012-1569-0
- By:
- Publication type:
- Article
A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications.
- Published in:
- International Journal of Environmental Research & Public Health, 2024, v. 21, n. 10, p. 1333, doi. 10.3390/ijerph21101333
- By:
- Publication type:
- Article
The Impact of COVID-19 on New Kidney Cancer Diagnosis: Stage and Treatment in Northern Italy.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 6, p. 4755, doi. 10.3390/ijerph20064755
- By:
- Publication type:
- Article
Chemotherapy-based regimens in multiple myeloma in 2020.
- Published in:
- Panminerva Medica, 2021, v. 63, n. 1, p. 7, doi. 10.23736/S0031-0808.20.04145-2
- By:
- Publication type:
- Article
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
- Published in:
- Oncogene, 2005, v. 24, n. 15, p. 2461, doi. 10.1038/sj.onc.1208447
- By:
- Publication type:
- Article
Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2390, doi. 10.3390/cancers16132390
- By:
- Publication type:
- Article
Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and Mortality.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3187, doi. 10.3390/cancers15123187
- By:
- Publication type:
- Article
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5846, doi. 10.3390/cancers14235846
- By:
- Publication type:
- Article
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5518, doi. 10.3390/cancers13215518
- By:
- Publication type:
- Article
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4898, doi. 10.3390/cancers13194898
- By:
- Publication type:
- Article
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3213, doi. 10.3390/cancers13133213
- By:
- Publication type:
- Article
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 896, doi. 10.3390/cancers11070896
- By:
- Publication type:
- Article
Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 6, p. 860, doi. 10.1111/ejh.14181
- By:
- Publication type:
- Article
Teclistamab‐cqyv in multiple myeloma.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 320, doi. 10.1111/ejh.14121
- By:
- Publication type:
- Article
Iron chelation therapy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 5, p. 490, doi. 10.1111/ejh.13935
- By:
- Publication type:
- Article
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 178, doi. 10.1111/ejh.13723
- By:
- Publication type:
- Article
Validation of the Alternative International Prognostic Score‐E (AIPS‐E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O‐CLL1‐GISL protocol.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 831, doi. 10.1111/ejh.13614
- By:
- Publication type:
- Article
Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 493, doi. 10.1111/ejh.13573
- By:
- Publication type:
- Article
High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 1997, v. 79, n. 11, p. 2107, doi. 10.1002/(SICI)1097-0142(19970601)79:11<2107::AID-CNCR7>3.0.CO;2-L
- By:
- Publication type:
- Article
Melphalan, Prednisone, and Lenalidomide for Newly Diagnosed Myeloma: Kinetics of Neutropenia and Thrombocytopenia and Time-to-Event Results.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 145
- By:
- Publication type:
- Article
Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases.
- Published in:
- Clinical Rheumatology, 2006, v. 25, n. 1, p. 80, doi. 10.1007/s10067-005-1138-1
- By:
- Publication type:
- Article
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684621
- By:
- Publication type:
- Article
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.640731
- By:
- Publication type:
- Article
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.643490
- By:
- Publication type:
- Article
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article